The Big Take
Generic Ozempic Makers Are Coming to Upend the Obesity Market
Cheap, regulated drugs are shaping up as one of the weight-loss market’s next big challenges.
In the eight years since Novo Nordisk A/S introduced Ozempic into the US, the diabetes shot has become synonymous with weight loss for everyone from Hollywood stars to Chinese influencers. Yet most of the world still has only limited access to the drug.
That is about to change dramatically.